Endocrinology, Diabetes & Metabolism Doctors in Riverside, RI Accepting Medicare

6 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 6

Tonslyn Toure, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4090    Fax: 401-649-4091

Geetha Gopalakrishnan, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl Ste 202b, Riverside, RI 02915 Phone: 401-649-4090    Fax: 401-649-4091

Harikrashna B. Bhatt, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl Ste 202b, Riverside, RI 02915 Phone: 401-649-4090    Fax: 401-649-4091

Vicky Cheng, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl Ste 202b, Riverside, RI 02915 Phone: 401-649-4090    Fax: 401-649-4091

Dr. Amanda J. Fernandes, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4090

Valerie Thomas, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 375 Wampanoag Trl, Riverside, RI 02915 Phone: 401-649-4090    Fax: 401-649-4091

News Archive

Sustained weight loss associated with reduced risk of breast cancer, shows study

A large new study finds that women who lost weight after age 50 and kept it off had a lower risk of breast cancer than women whose weight remained stable, helping answer a vexing question in cancer prevention.

Rare DNA variations may be responsible for differences in susceptibility to common disorders

One-letter switches in the DNA code occur much more frequently in human genomes than anticipated, but are often only found in one or a few individuals. The abundance of rare variations across the human genome is consistent with the population explosion of the past few thousand years, medical geneticists and evolutionary biologists report in the May 17 advanced online edition of Science.

IRIN examines whether poverty reduction schemes can help lower TB rate in developing countries

IRIN examines "whether a new generation of social protection schemes, aimed at reducing poverty and often using cash transfers to the poorest, can be harnessed to bring down the rate of tuberculosis (TB) in developing countries."

Lexicon Pharmaceuticals reports fiscal 2009 third-quarter results and updates of its clinical trials

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease, today updated its drug development progress and reported financial results for the three and nine months ended September 30, 2009.

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for "proliferating infantile hemangioma requiring systemic therapy".

Read more Medical News

› Verified 7 days ago